Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$5.48M Sell
30,812
-518
-2% -$95.2K 0.62% 38
2024
Q3
$6.19M Sell
31,330
-907
-3% -$169K 0.67% 37
2024
Q2
$5.53M Sell
32,237
-1,361
-4% -$225K 0.63% 40
2024
Q1
$6.12M Sell
33,598
-1,093
-3% -$188K 0.7% 38
2023
Q4
$5.38M Buy
+34,691
New +$5.06M 0.63% 42

Other funds holding ABBV

HTLF Bank's ABBV Position: Q4 2024 in Review

HTLF Bank reduced its AbbVie (ABBV) stake by 1.7% in Q4 2024, selling an estimated $95.2K and leaving 30,812 shares worth $5.48M. The position accounts for 0.62% of the portfolio, ranked #38.

HTLF Bank first reported a position in ABBV in Q4 2023 and has held it in 5 quarters since. The position peaked at $6.19M in Q3 2024. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • HTLF Bank held 30,812 shares of AbbVie worth $5.48M as of Q4 2024.
  • HTLF Bank sold 518 AbbVie shares in Q4 2024, an estimated $95.2K.
  • AbbVie made up 0.62% of HTLF Bank's portfolio in Q4 2024, its #38 holding.
  • HTLF Bank first reported a position in AbbVie in Q4 2023 and has held it in 5 quarters since.
  • HTLF Bank's AbbVie position peaked at $6.19M in Q3 2024.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on HTLF Bank's 13F filing for Q4 2024, filed 28 Jan 2025.